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Abstract
Background: Streptococcus agalactiae (Group B Streptococcus (GBS)) is an important human
pathogen, particularly of newborns. Emerging evidence for a relationship between genotype and
virulence has accentuated the need for efficient and well-defined typing methods. The objective of
this study was to develop a single nucleotide polymorphism (SNP) based method for assigning GBS
isolates to multilocus sequence typing (MLST)-defined clonal complexes.
Results: It was found that a SNP set derived from the MLST database on the basis of maximisation
of Simpsons Index of Diversity provided poor resolution and did not define groups concordant
with the population structure as defined by eBURST analysis of the MLST database. This was
interpreted as being a consequence of low diversity and high frequency horizontal gene transfer.
Accordingly, a different approach to SNP identification was developed. This entailed use of the
"Not-N" bioinformatic algorithm that identifies SNPs diagnostic for groups of known sequence
variants, together with an empirical process of SNP testing. This yielded a four member SNP set
that divides GBS into 10 groups that are concordant with the population structure. A fifth SNP was
identified that increased the sensitivity for the clinically significant clonal complex 17 to 100%.
Kinetic PCR methods for the interrogation of these SNPs were developed, and used to genotype
116 well characterized isolates.
Conclusion: A five SNP method for dividing GBS into biologically valid groups has been developed.
These SNPs are ideal for high throughput surveillance activities, and combining with more rapidly
evolving loci when additional resolution is required.
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Background
Streptococcus agalactiae (group B streptococcus; GBS) is a
significant human pathogen, particularly of newborn
infants. The population structure of this species has been
examined using restriction digestions of the genome [1],
pulse field gel electrophoresis [2] and multilocus
sequence typing (MLST) [3,4]. As a result of this work, it
is now well established that most GBS isolates can be
assigned to a small number of major lineages that are
(using MLST terminology) clonal complex (CC)19, CC1,
CC10, CC17 and CC23. CC19, CC1 and CC10 are related
to each other and also to a number of smaller/derived
CCs. It is also well established that CC17 represents a lin-
eage that is particularly associated with invasive disease
[1-3]. Some of us have developed a GBS typing system
that identifies serotype (and subtypes of serotype III), sur-
face protein gene profiles and several mobile genetic ele-
ments. This system is useful to monitor the distribution of
genotypes among invasive isolates from patients of differ-
ent age- and clinical groups and between invasive and col-
onising isolates [5,6]. There is a strong association
between a serotype III subtype (designated (msst) III-2 in
our genotyping system) and late onset neonatal sepsis [6],
and these subtypes are likely to be members of CC17. This
subtype can be easily distinguished from the most com-
mon serotype III subtype (III-1) and other less common
subtypes on the basis of the presence or absence of two
specific single nucleotide polymorphisms (SNPs) in the
cps gene cluster (between the 3' end of cpsE-cpsF and 5' end
of cpsG) [7].
The two most common (msst) serotype III, subtypes (III-
1 and III-2) correlate strongly, but imperfectly, with mul-
tilocus sequence types ST-19 and ST-17 respectively [8].
Other common serotypes also correlate with sequence
types, but there is some variation, suggesting considerable
lateral gene transfer or recombination. MLST is too expen-
sive for use in routine genotyping of GBS but a rapid
method which would allow identification of GBS clones
or clonal complexes (CCs) could have considerable utility
in clinical and public health microbiology and provide
complementary data for disease surveillance.
This study has made use of previously developed tech-
niques for the computerized derivation of small sets of
gene markers from sources of known genetic variation
such as multilocus sequence typing (MLST) databases [9-
15]. SNP sets can be combined with other binary markers
(as in our 3-set genotyping system), into different plat-
forms, such as multiplex PCR-based reverse line blot assay
[5] or other low density arrays, real-time PCR or various
"lab on a chip" technologies to provide comprehensive
and relatively inexpensive typing systems for microbial
surveillance and epidemiological studies. The software
package Minimum SNPs [9,12,15,16] is used to derive
marker sets. It uses DNA sequence alignments as input
and provides, as output, sets of SNPs with optimised
resolving power. The final resolving power depends on
the population biology of the species in question. For
example, in highly non-clonal, diverse species such as
Neisseria meningitidis and Streptococcus pneumoniae [17,18]
the high frequency of genetic exchange disrupts linkages
between the SNPs which define alleles of different house-
keeping genes, and allows resolving power to increase
approximately exponentially as SNPs are added to the set
[9]. However, there is incomplete correlation between the
SNP genotypes and the MLST-defined clonal complexes.
In Staphylococcus aureus, which has a much lower but still
significant recombination frequency [19], the resolving
power is less but the correlation between the SNP geno-
types and the MLST-defined CCs is high [10,11].
In this study, we investigated the population biology of
GBS using the well-established GBS MLST database
[3,4,21], and used this analysis to guide our approach to
the selection of a five member SNP set for identifying GBS
clonal complexes and ensuring high sensitivity for CC17.
A genotyping assay based upon these SNPs was reduced to
practice.
Methods
Bacterial Isolates
Most of the 116 GBS isolates used in this study were from
routine antenatal swabs and were assumed to be repre-
sentative of GBS colonising strains; 12 were isolates from
normally sterile sites (mainly blood; no other clinical data
available) and the origins of six isolates were unknown.
The isolates were kindly provided by Catherine Satzke and
Roy Robins-Browne, Royal Children's Hospital, Mel-
bourne. Genotyping had been performed, as previously
described [5]. For complete information regarding the iso-
lates, [see additional file 1].
Bioinformatic analyses
The computer program Minimum SNPs is used to derive
SNP sets with optimised resolving power from sequence
alignments in the MLST database [9,12,15]. SNP sets are
assembled empirically, with three measures of resolving
power available to the user, namely:
1. defined variant (or %) mode, which measures resolving
power on the basis of the ability of the SNPs to discrimi-
nate one user-defined sequence variant from all known
sequence variants,
2. D-maximisation mode, which measures resolving
power on the basis of the Simpsons Index of Diversity of
the SNP-defined genotypes as calculated against the com-
plete sequence alignment, and
3. Not-N mode, which measures resolving power on the
basis of the ability of the SNPs to discriminate a user-BMC Microbiology 2008, 8:140 http://www.biomedcentral.com/1471-2180/8/140
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defined group of sequence variants from all other
sequences.
Other useful functions are the ability to exclude positions
in the alignment from the analysis, to force inclusion of
positions in the alignment in the program output, and to
"work backwards" i.e. to determine which sequences in an
alignment are consistent with a given SNP profile.
Minimum SNPs, with full documentation, is available for
download from [16].
A generalised approach to assessing the power of SNPs to
identify groups of STs (e.g. CCs) was developed during the
course of this study. We reasoned that the problem is
effectively identical to assessing the performance of any
diagnostic procedure, and so the appropriate descriptors
are sensitivity, specificity and positive predictive value
(PPV). In this context, true positive (TP) represent STs that
belong to the CC of interest and are genotyped correctly;
false positives (FP) are STs that do not belong to the CC of
interest but are genotyped as if they do; true negatives
(TN) are STs that do not belong to the CC of interest and
are genotyped correctly, and false negatives (FN) represent
STs that belong to the CC of interest but are genotyped as
if they do not.
Sensitivity (TP/[TP + FN]) is the probability that an isolate
belonging to the CC of interest will be genotyped as such.
Specificity (TN/[TN +FP]) is the probability that an isolate
that does not belong to the CC of interest will be geno-
typed as such.
PPV (TP/[TP + FP]) represents the proportion of isolates
that type as a CC member that are correctly identified.
eBURST [22,23] is a method for depicting the population
structure of bacteria that is not dependent upon the con-
struction of tree topology. It is therefore suitable for
depicting non-clonal species. The input for eBURST anal-
ysis is MLST allele profiles, and the program works by
identifying CC progenitors on the basis that within a clus-
ter of related STs, the progenitor will be the ST that is sep-
arated from the greatest number of other STs by a
difference at just one locus. The STs that differ from the
presumed progenitor at just one locus are termed single
locus variants (SLVs), while those that differ from the pro-
genitor at two loci are termed double locus variants
(DLVs).
DNA extraction method
Isolates were subcultured onto brain heart infusion agar
(BHIA; Oxoid) and incubated at 37°C for 24 hrs.
Genomic DNA was obtained by a new mutanolysin-based
extraction method. Two loopfuls of cells were resus-
pended in 500 μL of water containing 50 U of
mutanolysin (Sigma Aldrich) incubated at 56°C for one
hour, boiled for ten minutes at 100°C, and placed on ice
to cool. Tubes were centrifuged at full speed in a micro-
fuge for three minutes, and the supernatant collected and
stored at 4°C.
PCR set up and cycling conditions
Real-time PCR was carried out on the ABI7300 device
(Applied Biosystems). Each reaction contained 5 pmol of
each primer, 1 μL of genomic DNA, 10 μL of Applied Bio-
systems SYBR Green MasterMix, and molecular grade
water to a final volume of 20 μL. For the glnA429 reac-
tions, double the amount of primer was used (10 pmol
each primer) to obtain reliable amplification.
The PCR protocol was as follows: 50°C for two minutes,
followed by a stage at 95°C for 10 minutes; 95°C for 15
seconds, and 60°C for one minute for 40 cycles.
The dissociation stage was 60°C–95°C.
Primer sequences
The primer sequences for the kinetic PCR reactions are
shown in Table 1.
Ethics
This experimental work has been approved by the Sydney
West Area Health Service Human Research Ethics Com-
mittee (New South Wales, Australia).
Results and discussion
SNP identification
The aim of this study was to identify a small SNP set that
can resolve the major GBS clonal complexes as defined by
eBURST analysis of the GBS MLST database. Firstly we
assessed the utility of the D-maximisation SNP selection
method that, in the case of S. aureus, yielded a SNP set
with good resolving power and good correlation between
SNP profile and clonal complex structure. However, for
GBS the rate of increase of D per SNP added to the set was
lower than any other bacterial species tested so far (Heli-
cobacter pylori, Neisseria meningitidis, Campylobacter jejuni/
Campylbacter coli, Burkholderia pseudomallei, Streptococcus
pyogenes, Streptococcus pneumoniae, Staphylcoccus aureus)
(Robertson et al, 2004). Eleven SNPs were required to
reach D = 0.95, while the previous worst performer in the
accumulation of D per SNP was S. aureus, which required
seven SNPs to reach D = 0.95 [9]. In addition, the correla-
tion between SNP profile and clonal complex structure
was poor (data not shown).
The reason for the poor performance of the D maximised
SNP set was investigated. GBS displays very little diversityBMC Microbiology 2008, 8:140 http://www.biomedcentral.com/1471-2180/8/140
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among MLST allele sequences; Jones et al (2003) reported
that sequence variation ranges from 1.2% to 2.5% at dif-
ferent MLST loci. Moreover, examination of the MLST
database reveals that approximately 45% of eBURST-
defined single locus variants are generated through the
acquisition of a pre-existing allele, rather than by the gen-
eration of a new allele through presumed mutation (data
not shown). This indicates that the species' horizontal
gene transfer rate is at least comparable to point mutation.
Minimum SNPs-based derivation of D-maximised SNP
sets from non-clonal microbial species usually provides
an almost exponential increase in D as SNPs are added to
the SNP set [9]. This is because of the low linkage between
SNPs; in an entirely clonal species each SNP can only
define one type so the resolving power increases arithmet-
ically as SNPs are added to the set. In practice, the limiting
factor in non-clonal species is that the existence of a SNP
that provides a truly exponential increase in resolving
power becomes less likely as the size of the SNP set
increases. This is because, even when there is frequent hor-
izontal gene transfer, the probability that a single SNP will
by chance divide each of a number of different subsets of
known sequences into equal halves is much less than the
probability that a single SNP will divide all known
sequences into equal halves. It therefore follows that the
smaller the pool of SNPs to select from, the earlier and
greater the deviation from an exponential increase in
resolving power, as SNPs are added to the D-maximised
set. Thus our current understanding of D-maximised SNP
sets derived from GBS MLST data is that significant hori-
zontal gene transfer disrupts that relationship between
SNP profile and population structure, and a paucity of
SNPs to choose from means that the resolving power of D-
maximised SNP sets is poor with respect to comparably
sized SNP sets derived from the MLST databases of other
non-clonal bacterial species.
Accordingly it was concluded that D maximisation is not
the optimum approach for identifying a useful SNP set for
GBS, and that a new approach was needed. It was also
concluded that while sets of 7–8 SNPs provide a very good
compromise between number of SNPs and resolving
power for other bacterial species [9], the lack of SNPs
defined by the GBS MLST database and the results of the
D-maximisation experiments suggest that the optimum
size of a generally applicable GBS-genotyping SNP set will
be smaller than 7–8, irrespective of the SNP identification
method used.
The alternative strategy that was developed involved the
use of the Minimum SNPs Not-N algorithm [15] to find
SNPs diagnostic for the major CCs, and then a process of
empirical SNP set editing and testing, facilitated by the
Minimum SNPs "include and exclude" functions, and
"working backwards" (from SNP profile to STs) mode.
This process was directed towards finding different SNP
sets that are diagnostic for different CCs, but that also hap-
pen to include at least some of the same SNPs. The out-
come was a set of four SNPs that are informative across the
GBS species and define genotypes strongly correlated with
Table 1: Sequences of primers used in kinetic PCR reactions.
SNP Primer Name Primer Sequence (5' – 3')
glnA36 glnA36-C ATATCCTGATTTAGATACTTGGATTCTC
glnA36-T ATATCCTGATTTAGATACTTGGATTCTT
glnA36-Rev TCTCCTTCTGCTGTATAGATATCACA
glnA4291 glnA429-G1 TTGTTTTAACAACCAATTTAAATAATTGAATC
glnA429-A TTGTTTTAACAACCAATTTAAATAATTGAATT
glnA429-For AAGTAGCAGTTGGACAGGATGAAA
glcK180 glcK180-A GGCTGATACTCAAGAAGTAGGTTAA
glcK180-G GGCTGATACTCAAGAAGTAGGTTAG
glcK180-Rev ACCAAGTGCTGCAACATTAGC
adhP111 adhP111-G TTGCATGGTTCTTTGAATGG
adhP111-A TTGCATGGTTCTTTGAATGA
adhP111-T TTGCATGGTTCTTTGAATGT
adhP111-Rev CAAAGCGTCTCACGTCCTGT
atr351 atr351-A GTTGTTGTTGTCCTCCAGATAAGCTA
atr351-T GTTGTTGTTGTCCTCCAGATAAGCTT
atr351-Rev GGACTCAAAGAGAAGGCTAATGCT
The allele specific primers are named in accordance with their specificities, while the common primers are names in accordance with their 
orientation with respect to the coding DNA sequences.
1The glnA429 allele specific primers are in the reverse direction, hence the inconsistency between the alleles and the 3' terminal nucleotides.BMC Microbiology 2008, 8:140 http://www.biomedcentral.com/1471-2180/8/140
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the population structure as defined by eBURST analysis.
These SNPs are glnA36, glnA429, glcK180, and adhP111.
The positions of these in the concatenated MLST database
are 1536, 1929, 2697 and 111 respectively.
A complete description of the relationship between the
SNP profiles and the GBS MLST-defined population struc-
ture was determined, using the MLST database as down-
loaded on April 4, 2007. This was accomplished using the
"working backwards" mode of Minimum SNPs. An over-
view of the results is shown in Table 2 and Fig 1. For full
details, [see additional file 2 and additional file 3].
eBURST analysis divides GBS into three large groups and
a number of singletons. Many of the singletons are DLVs
of the founders of major groups so their status as "true"
singletons that are clearly diverged from other groups
within the species is dubious. The largest eBURST defined
group is an extensively interlinked network that encom-
passes several different examples of clonal expansion and
diversification, the largest of which are derived from ST-1,
ST-19, and ST-10. The other major eBURST groups are less
complex in structure and are derived from ST-17 and ST-
23 respectively. Two ST-17 derivatives, ST-67 and ST-22,
have themselves given rise to clonal expansion and diver-
sification. Because of the differing degrees of complexity
of eBURST groups, defining what constitutes a CC is not
straightforward. In this paper, we define a CC as incorpo-
rating a successful ST and its SLVs, unless stated otherwise.
An additional SNP that improves sensitivity for CC17
The correspondence between the generally applicable
SNP profiles, and the GBS population structure as
revealed by eBURST analysis is good, but imperfect. A sig-
nificant contributor to this is the inability of eBURST anal-
ysis to generate a reliable population structure from a high
frequency recombination species. This is a limitation
determined by differences in evolutionary history
between different parts of the genome, rather than of the
eBURST algorithm itself. This phenomenon is particularly
evident with the large highly interlinked eBURST group
that contains CC1, CC19 and CC10, and a number of
smaller/derived CCs. eBURST analysis cannot reliably
define precise evolutionary pathways with this popula-
tion structure because there are so many essentially equiv-
alent topologies. A consequence of this is that any given
topology will inevitably result in very closely related STs
sometimes being separated by many steps in the eBURST
diagram. Therefore, assigning isolates to particular clones,
with a high level of confidence, is not possible within such
a highly interlinked population.
Nevertheless, if CC membership is clinically relevant, false
negatives may be a serious problem. Accordingly we
developed a strategy to minimise false negatives for
defined groups of STs. During the course of this study we
observed that if the "defined variant" algorithm in Mini-
mum SNPs is used to identify SNPs diagnostic for a spe-
cific CC founder, the first one or two SNPs in the series
will differentiate the CC from the rest of the population,
and the later SNPs in the series will distinguish the CC
founder from its double and single locus variants. This
approach alone produces similar false positive and nega-
tive rates to those produced with the four generally appli-
cable SNPs described above and so is therefore less
efficient, because different SNP sets are required for each
CC. However, given that a generally applicable SNP set
has been already been developed using other means, we
postulated that for any given CC, the false negatives
would be different for a "CC founder specific SNP", and
the four generally applicable SNPs. Therefore, a strategy in
which a single CC-specific SNP was interrogated in iso-
lates that are negative for that CC on the basis of the gen-
erally applicable SNPs would ensure that no single locus
variants were missed. We have termed such a SNP a
"safety net SNP". It was also postulated that the safety net
SNP would be effective in reducing false positives from
the generally applicable SNP set. As with the "false nega-
tive" problem, we hypothesised that the false positives
from the safety net SNP, and the generally applicable
SNPs would not overlap.
This strategy was tested using CC17 as a model system,
because this CC is generally regarded as causing a high
Table 2: Overview of the relationship between SNP profiles and GBS population structure
SNP profiles (in order: glnA36, glnA429, glcK180, adhP111) Clonal complex
CTAG CC1
CTAA CC10
CCGG CC17
CCAG CC19
TCGG CC23 (also includes CC22)
CTGG CC67
CCAA Four CC1 members and four singletons (no CC founders)
TCAG Seven STs, scattered throughout population (no CC founders)
TCAA ST227, ST159
CCGT ST137BMC Microbiology 2008, 8:140 http://www.biomedcentral.com/1471-2180/8/140
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proportion of paediatric infections, and is potentially a
valuable diagnostic target.
If CC17 is defined as consisting of ST-17 plus its single
locus variants, the generally applicable SNPs provide very
good sensitivity and specificity (Table 3). The ST-17 single
locus variants that are missed by the generally applicable
SNP set are ST-128 (CC23 profile), ST-137 (unique pro-
file), ST-146 (ST-67 profile) and ST-174 (ST-23 profile)
i.e. these are false negatives. (In contrast, 46 ST-17 single
locus variant i.e. true positives give the CC17 profile when
interrogated at the generally applicable SNPs, [see addi-
tional file 3 and additional file 4]. It is arguable that only
ST-128 and ST-174 are problematic, because ST-137 has a
unique profile on the basis of the generally applicable
SNPs profile.
Minimum SNPs "Defined variant" analysis for ST-17
revealed that the single most discriminatory SNP (i.e
SNP1 in the program's output) is atr351 (position 1350 in
the concatenated database), with ST-17 possessing the "A"
allele. This allele eliminates the four false negatives, so we
term atr351 the "safety-net" SNP. Eighty-five (27.1%) of
known GBS STs possess the A allele, so at first analysis,
this SNP appears to generate a large number of false posi-
tives for CC17. However, the great majority of these STs
are members of CC17, or the closely related CCs, CC67
and CC22. Remarkably, only five STs that are "A" at the
safety net SNP are not members of the eBURST group that
contains CC17, CC67 and CC22.
An unanticipated benefit of interrogating the safety net
SNP is that it is very effective at resolving CC22 and CC23,
which are not resolved by the generally applicable SNPs.
The only CC22 members which do not type as CC17 on
the basis of the safety net SNP are ST-168 and ST-169
(which, similarly to other ST22 members, type as CC23
on the basis of the generally applicable SNPs.) In sum-
mary, the safety net SNP may be qualitatively regarded as
being very effective at discriminating CC17, together with
the closely related CC67 and CC22, from other CCs
within the species.
Quantifying the performance of the safety net SNP is not
straightforward, because it is designed to provide an alter-
native or back-up to the generally applicable SNP set, as
Overview of relationship between eBURST defined GBS  population structure and generally applicable SNP profiles Figure 1
Overview of relationship between eBURST defined 
GBS population structure and generally applicable 
SNP profiles. The group definition was set to zero, so as to 
provide a population snapshot. The depicted relationship 
between STs and SNP profiles is approximate. For definitive 
information, see [additional files 2, 3, 4.].
TCGG: 
CC23,
CC22
CCAG: CC19
CTAG: CC1
CTAA: CC10
“A” allele, safety net
CCGG: CC17
CTGG: CC67
Table 3: Informative powers of SNP sets.
Generally applicable SNP profile CCGG1as a diagnostic for CC17.
Calculated against all STs Sensitivity = 0.91 Specificity = 0.98 PPV = 0.90
Safety net SNP atr351 "A" allele of as a diagnostic for CC17 – calculated against subsets of STs defined by generally applicable 
SNPs
CC67 profile STs Sensitivity = 1 Specificity = 0.13 PPV = 0.07
CC23 profile STs Sensitivity = 1 Specificity = 0.79 PPV = 0.14
CC17 profile STs Sensitivity = 1 Specificity = 1 PPV = 1
Safety net SNP "A" allele as a diagnostic for CC17
Calculated against all STs Sensitivity = 0.92 Specificity = 0.82 PPV = 0.45
Safety net SNP "A" allele as a diagnostic for CC17, CC67, CC22 eBURST group
Calculated against all STs Sensitivity = 0.94 Specificity = 0.95 PPV = 0.85
1. The generally applicable SNP profile consists of alleles at glnA36, glnA429, glcK180, and adhP111; the safety net SNP is atr351BMC Microbiology 2008, 8:140 http://www.biomedcentral.com/1471-2180/8/140
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opposed to simply adding another allele to the SNP pro-
file of the diagnostic target. The most informative
approach is to calculate its performance separately against
groups of STs that return particular profiles when interro-
gated at the generally applicable SNPs. This is because the
different generally applicable SNPs-defined groups of STs
differ greatly with respect to the proportion that possess
the CC17 "A" allele at the safety net SNP. A corollary of
this is that the profile obtained from the generally appli-
cable SNPs may potentially indicate whether it is worth-
while interrogating the safety-net SNP at all.
As stated above, the three CC17 false negatives as defined
by the generally applicable SNPs return two different pro-
files – those associated with CC67, and CC23. The specif-
icity of the safety-net SNP differs greatly as a function of
which generally applicable SNP profile has been obtained
(Table 2). In the case of the STs that return the CC67 pro-
file, the specificity provided by the safety-net SNP for
CC17 is low because essentially all CC67 members pos-
sess an "A" allele at the safety net SNP. In contrast, only a
minority of the CC23 STs have an "A" allele at the safety-
net SNP, so the specificity of the safety net SNP for CC17
with this group of STs is better. Accordingly, if this geno-
typing approach were being used to monitor GBS popula-
tions, and also to diagnose or detect CC17 members with
maximal sensitivity, a possible work flow may be as fol-
lows:
1. Interrogate at the generally applicable SNPs
2. For any SNP profiles other than those matching CC67
or CC23, terminate the procedure and record the results.
3. When a profile matching either CC67 or CC23 is
obtained, Either:
A. Interrogate the isolate at the safety-net SNP, and classify
as CC17 if it possesses the "A" allele, or
B. Simply regard any CC67 profile isolates as CC17, on
the basis that the profile is not common, the specificity of
the safety-net SNP is low, and CC67 is closely related to
CC17; interrogate CC23 profile isolates at the safety-net
SNP and regard any that possess the "A" allele as CC17
members.
The utility of the safety net SNP for eliminating ST-17 false
positives as defined by the generally applicable SNPs was
also tested. The five non-CC17 STs that return the ST-17
generally applicable SNP profile are ST-81 (CC19), ST-86
(CC-19), ST-226 (not part of a major CC), ST-271 (CC67)
and ST305 (ST23). None of these possess an A allele at the
safety net SNP apart from ST-271 which, is arguably part
of CC-17 anyway. Therefore, the safety net SNP is very
effective eliminating CC17 false positives.
The power of the safety net SNP on its own to serve as a
CC17 diagnostic is also of interest. As stated above, the
general property of this SNP is that it discriminates the
closely related CCs CC17, CC22 and CC67 from the rest
of the species. eBURST analysis puts these CCs into a sin-
gle group. The specificity, sensitivity and PPV provided by
this SNP in diagnosing either ST17 plus single locus vari-
ants (narrow definition of CC17), or the CC17–CC22–
CC67 eBURST group (wide definition of CC17) were cal-
culated. As expected, this SNP provides high sensitivity
against both targets, and high specificity and PPV against
the CC-17–CC22–CC67 eBURST group (Table 2).
Therefore, it was concluded that a five SNP set consisting
of positions glnA36, glnA429, glcK180, and adhP111 as
generally applicable SNPs, and atr351 as a CC17 safety net
SNP, would provide general discriminatory power right
across the GBS species, and provide a particularly high
level of sensitivity for CC17. In addition, interrogation of
atr351 on its own shows potential as a diagnostic for the
CC17–CC22–CC67 eBURST group. A number of SNP-
based approaches to bacterial genotyping have been
reported by other groups, [27-29], but the approach taken
in this study to identifying a SNP set and quantifying its
performance is to our knowledge unique.
SNP interrogation
Kinetic PCR methods for interrogating the SNPs were
developed using known sequences. Isolates 1, 5, 9, 29, 30,
34 and 79 were subjected to full MLST analysis, and these
were used both in method development and also as con-
trols in when genotyping unknown isolates [see addi-
tional file 1]. In addition, sequencing of the adhP locus
from isolate 2 revealed that it is MLST allele 4, which pro-
vides the adhP111 SNP allele "A" at this position. This
provided known sequences representing all SNP alleles,
with the exception of the "T" allele of adhP111. This is very
rare, and to date has been found only in ST-137.
Initial experiments on known sequences revealed that the
kinetic PCR SNP interrogation is robust, with the ΔCT val-
ues clearly discriminating the alleles. (Table 4).
One hundred and sixteen isolates were subjected to SNP
typing. The results are summarised in Table 5. For com-
plete results [see additional file 1]. On the basis of the four
generally applicable SNPs, 22 were allocated to the CC1
profile, 16 to CC10, six to CC17, 50 to CC19, 21 to CC23
and one (isolate 91) to a new profile, CAGT. The DNA
yielding this new profile was subjected to complete MLST
analysis, and the presence of multiple double peaks in the
sequencing traces indicated that the DNA was obtained
from a mixed culture, and that in consequence this new
profile was an experimental artefact. This was not fol-
lowed up further. Isolates belonging to CC17 have previ-
ously been shown to essentially always be msst MSIII, andBMC Microbiology 2008, 8:140 http://www.biomedcentral.com/1471-2180/8/140
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to possess the pgp "R" profile and mge IS861-GBSi1 pro-
file [5,8]. All but one of the isolates returning the CC17
generally applicable SNP had these characteristics, thus
providing strong supporting evidence that the SNPs are
indeed identifying CC17 (Table 5) Another very abundant
msst MSIII clone in Australia belongs to CC19, and pos-
sesses the pgp "R" profile and the mge profile IS1381-
IS861-GBSi1. Of the 116 isolates, 38 possessed these char-
acteristics and the CC19 SNP profile. Therefore, the SNPs
are effective discriminating between these major msst
MSIII groups.
Table 4: Differential amplification kinetics for the SNP alleles.
SNP ΔCT ± SD (allele 1) ΔCT ± SD (allele 2) ΔΔCT
glnA36 7.6 ± 1.0 (C) 7.5 ± 1.2 (T) 15.1
glnA429 10.9 ± 3.0 (C) 3.9 ± 2.5 (T) 14.8
glcK180 8.5 ± 2.4 (A) 11.1 ± 1.7 (G) 19.6
adhP111 14.9 ± 1.6 (G) 9.5 ± 2.0 (A) 24.4
Atr351 (safety net) 2.1 ± 0.6 (T) 6.6 ± 0.5 (A) 8.7
The ΔCT is the CT for the reaction containing the mis-matched primer – the CT for the reaction containing the matched primer. SD is the standard 
deviation. The ΔΔCT is the difference between the two ΔCT values and represents the SNP signal.
Table 5: Relationship between CCs identified by SNP typing, and genotype
CLONAL COMPLEX SNP PROFILE MOLECULAR 
SEROTYPE (MS)1
PROTEIN GENE 
PROFILE (PGP)1
MOBILE GENETIC 
ELEMENTS (MGE)1
N = 116 (SSI)2
CC 1 (n = 22) CTAG V Alp3 1S1381 10 (3)
VA l p 3 N o n e 1
V- G B S i 1 1
Ia Alp1 GBSi1 2
Ia Alp1 IS861-GBSi1 1
Ia Alp1 None 1
II Alp1 IS1381-ISsAg4-GBSi1 1 (1)
II Alp1 IS1381-ISsAg4 1
III Alp3 IS1381-GBSi1 1
VII Alp3 1S1381 2
VII A IS1381 1
CC 10 (n = 16) CTAA Ib A IS1381-IS861 13
II A IS1381-IS861-IS1548 1
II A IS1381-IS861-ISsAg4 1
VAI S 1381-IS861 1
CC 17 (n = 7) CCGG III R IS861-GBSi1 6 (1)3
Ia Alp1 IS1381 14
CC 19 (n = 50) CCAG III R IS1381-IS861-GBSi1 38 (4)5
II R IS1381-IS861-IS1548 8
V- G B S i 1 1
V Alp3 IS861-GBSi1 1 (1)
V Alp3 GBSi1 1
CC 23 (n = 21) TCGG Ia Alp1 IS1381 16 (2)
Ia Alp1 IS1381-IS861 1
Ia Alp2 - 1
V Alp1 IS1381-IS861 2
II Alp2 - 1
New profile6 TCAG III R IS1381-IS861-IS1548 1
1For description of methods of identification of molecular serotype (MS), protein gene profiles (pgp) and mobile genetic elements (mge) see [5].
2SSI – sterile site isolates. Figures in brackets indicate the small subset of isolates from blood or CSF cultures from patients of varying ages. All 
others were from routine antenatal vaginal swabs or their sites of isolates were unknown (5 isolates). No attempt was made to identify differences 
between invasive and colonising isolates among those studied.
3The profile MS III-pgp R-mge IS861-GBSi1 is typical of the virulent serotype III subtype, which we have found previously to be associated with late 
onset neonatal sepsis) [6].
4This isolate was shown to not be CC17 by interrogation of the safety net SNP.
5The profile MSIII-pgp R-mge IS1381-IS861-GBSi1 is typical of the most common serotype III subtype, which is commonly found among vaginal 
isolates and is also a common cause of neonatal sepsis.
6This profile was derived from a mixed DNA sample and is likely an artefact.BMC Microbiology 2008, 8:140 http://www.biomedcentral.com/1471-2180/8/140
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Interrogation of the safety net SNP revealed that the gen-
erally applicable SNPs generated one false positive and no
false negatives for CC17. As expected, the false positive
(isolate 6 [see additional file 1]), was the one isolate that
returned the CC17 generally applicable SNP profile, and
is not msst MSIII. The lack of CC17 false negatives for the
isolates that typed as CC1, CC10 or CC19 at the generally
applicable SNPs was expected, because according to the
MLST database, these generally applicable SNP profiles
never co-exist with "A" at the safety net SNP. The only
non-CC17 generally applicable SNP profiles that co-exist
with "A" at the safety net SNP are the CC67 profile (which
none of the isolates in this study possess) and the CC23
profile. The MLST database defines a significant number
of CC23 generally applicable SNP profile STs that are "A"
at the safety net SNP, and almost all of these are in CC22,
which is very closely related to CC17. The fact that none
of the isolates tested in this study are CC23 on the basis of
the generally applicable SNPs and "A" at the safety-net
SNP indicates that none of them are CC22.
This study is similar in it its objectives to that described by
Lamy et al [24]. However, their method provided no
information beyond whether or not an isolate is part of
the virulent CC17 taxon, and it is unclear whether their
method is specific for the whole CC17, or only for the ST-
17 clone. It is significant that a putative virulence factor
associated with ST-17, Srr-2, has also been found in an ST-
17 SLV [25]. It is also similar in its objectives to that
described by Tong et al [7], although this relies on molec-
ular serotyping to identifying MSIII isolates, and then
makes use of a SNP to discriminate MSIII CC17 isolates
from MSIII CC19 isolates. Our method is entirely based
on SNPs, and provides typing information across the
entire species. Similar studies in other species that define
SNPs diagnostic for biologically valid sub-groups of bac-
terial species include [26-29]. Interrogation of the SNPs
we have described could easily be combined with interro-
gation of rapidly evolving loci so as to yield a hierarchical
genotyping method similar to that described for Bacillus
anthracis [30] or Campylobacter jejuni [31].
Conclusion
We have developed a GBS CC genotyping method based
upon four MLST database-derived SNPs that resolve the
major eBURST-defined clonal complexes. An additional
SNP increases the sensitivity and specificity of GBS CC17
diagnosis. A real-time PCR based assay for interrogating
these SNPs has been developed. This method represents
an efficient means of classifying GBS into groups that are
concordant with the population structure. These SNPs
could be used on their own, or combined with other rap-
idly evolving markers so as to yield highly informative
genotyping methods.
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